Aperçu gratuit du livre Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
* Offre en vigueur du 28 novembre au 2 décembre 2024 dans les magasins au Canada et à indigo.ca avec tout achat d'au moins 50 $ d’articles admissibles, avant les taxes, mais après les rabais applicables et l’échange de points. Le montant d’achat minimal exclut les cartes-cadeaux, les frais d'abonnement ou de renouvellement à plum+, les frais d’expédition, les produits de la Fondation Indigo pour l'amour de la lecture et les dons faits à celle-ci. La sélection offerte en magasin et en ligne peut varier.
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit/fr-ca/pricing-of-drugs-codeveloped-by-federal-laboratories-and-private-companies-hearing-before-the-subcommittee-on-regulation-business-opportunities-and-technology-of-the-commit/5D7C80F3-4359-406D-AB71-092DAD0B8D15.html5D7C80F3-4359-406D-AB71-092DAD0B8D15
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi